 EWING, N.J., April 26, 2021 GLOBE NEWSWIRE -- Antares Pharma, Inc. NASDAQ: ATRS the Company, a specialty pharmaceutical company, today announced the appointment of Peter Richardson, MRCP, as Executive Vice President, Research and Development and Chief Medical Officer. In this role, Dr. Richardson will oversee the Companys proprietary research and development programs, including ideation, formulation, clinical operations, pharmacovigilance and medical affairs. 